Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
The Nikkei 225 index fell 4.00% intraday, currently trading at 60,446.87 points.
2026-11-04
The Nikkei 225 index fell 4.00% intraday, currently trading at 60,446.87 points.
Back
Other News
2026-11-03
Southbound capital saw a significant net inflow of HK$23.42 billion today. In the Shanghai-Hong Kong Stock Connect, the Tracker Fund of Hong Kong (TRX) and the Southern Hang Seng Technology Index saw net inflows of HK$11.518 billion and HK$1.948 bill
Southbound capital saw a significant net inflow of HK$23.42 billion today. In the Shanghai-Hong Kong Stock Connect, the Tracker Fund of Hong Kong (TRX) and the Southern Hang Seng Technology Index saw net inflows of HK$11.518 billion and HK$1.948 billion respectively; Xiaomi Group-W saw the largest net outflow at HK$339 million. In the Shenzhen-Hong Kong Stock Connect, the TRX and the Hang Seng China Enterprises Index saw net inflows of HK$4.989 billion and HK$2.384 billion respectively; Genscript Biotech-1000 saw the largest net outflow at HK$341 million.
2026-11-04
Hong Kong-listed innovative-drug stocks extended gains: WuXi AppTec (02359.HK) and BeiGene (06160.HK) rose more than 5%; WuXi Biologics (02269.HK) and Kangfang Biotech (09926.HK) also advanced.
Hong Kong-listed innovative-drug stocks extended gains: WuXi AppTec (02359.HK) and BeiGene (06160.HK) rose more than 5%; WuXi Biologics (02269.HK) and Kangfang Biotech (09926.HK) also advanced.
Chat with us
, powered by
LiveChat